Azacitidine and Risperidone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azacitidine (azacitidine) and Risperidone (risperidone). Common drug interactions include neutropenia among females and interstitial lung disease among males.

The phase IV clinical study analyzes what interactions people have when they take Azacitidine and Risperidone. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Risperidone?

Risperidone has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 72,175 Risperidone users. Check the latest studies of Risperidone.



On Jul, 18, 2026

38 people who take Azacitidine and Risperidone together, and have interactions are studied.

Azacitidine and Risperidone drug interactions.

What are the common drug interactions of Azacitidine and Risperidone, by gender? *:

female:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Somnolence (a state of near-sleep, a strong desire for sleep)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Vomiting
  5. Arthralgia (joint pain)
  6. Fall
  7. Hospitalisation
  8. Infection
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Terminal state (the transitional states between life and biological death)

male:

  1. Interstitial lung disease
  2. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Pneumonia
  5. Pneumonia fungal
  6. Pneumonia necrotising (necrotizing pneumonia is a life-threatening condition in which a person breathes material into his or her lungs)
  7. Pulmonary alveolar haemorrhage (acute bleeding)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Asthenia (weakness)
  10. Dizziness

What are the common drug interactions of Azacitidine and Risperidone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dysarthria (speech disorder)
  2. Haematotoxicity (toxins that destroy red blood cells)
  3. Jc virus infection
  4. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)

50-59:

  1. Interstitial lung disease
  2. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypoxia (low oxygen in tissues)
  5. Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood)
  6. Pyrexia (fever)
  7. Pulmonary toxicity (side effects on the lungs)

60+:

  1. Blood glucose increased
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Dizziness
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Pneumonia
  7. Pneumonia fungal
  8. Pneumonia necrotising (necrotizing pneumonia is a life-threatening condition in which a person breathes material into his or her lungs)
  9. Asthenia (weakness)
  10. Pulmonary alveolar haemorrhage (acute bleeding)

What are the existing conditions these people have? *

  1. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 27 people, 71.05%
  2. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 20 people, 52.63%
  3. High Blood Pressure: 13 people, 34.21%
  4. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 12 people, 31.58%
  5. Dyslipidaemia (abnormal amount of lipids): 12 people, 31.58%
  6. Insomnia (sleeplessness): 12 people, 31.58%
  7. Type 2 Diabetes: 12 people, 31.58%
  8. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 11 people, 28.95%
  9. Personality Change: 10 people, 26.32%
  10. Aggression: 8 people, 21.05%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and Risperidone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azacitidine and Risperidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azacitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Risperidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azacitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Risperidone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on azacitidine and risperidone (the active ingredients of Azacitidine and Risperidone, respectively), and Azacitidine and Risperidone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: